The association between the survivin gene -31G/C polymorphism and risk of hepatocellular carcinoma in Egyptian population. | ||||
| Journal of Advanced Biomedical and Pharmaceutical Sciences | ||||
| Article 3, Volume 7, Issue 3, July 2024, Page 103-108 PDF (413.16 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/jabps.2024.278357.1217 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Heba Eltahir1; Sherif Ali Maher2; Mahmoud Elrihany3; Hala Ibrahim Mohamed4; Ahmed wahid5; Amer A Alamri6; Sultan Al thagfan7; Meky M Abouzied8; Abdel-Gawad S Shalkami9; Michael A Fawzy  10
| ||||
| 1Department of Pharmacology and Toxicology, College of Pharmacy, Taibah University, Al-Madinah Almunawwarah, Kingdom of Saudi Arabia | ||||
| 2Department of Biochemistry, Faculty of pharmacy, New valley University, New Valley, El-kharga city 71511, Egypt | ||||
| 3Department of Biochemistry, Faculty of pharmacy, Deraya University, New Minia city 61111, Egypt | ||||
| 4Department of hepatology and gastroenterology, Faculty of medicine, Minia University, Minia city 61519, Egypt | ||||
| 5Department of Biochemistry, Faculty of pharmacy, Alexindria University, Egypt | ||||
| 6Medical center Taibah University, Medina, Kingdom of Saudi Arabia | ||||
| 7Department of clinical and hospital pharmacy, College of Pharmacy, Taibah University, Medina, Kingdom of Saudi Arabia | ||||
| 8Department of Pharmacology and Toxicology, College of Pharmacy, Taibah University, Madinah, Saudi Arabia. | ||||
| 9Clinical Pharmacy program, Al-Rayan Colleges, Medina, Kingdom of Saudi Arabia | ||||
| 10Department of faculty of Pharmacy, Minia University, Minia, Egypt | ||||
| Abstract | ||||
| Background: Survivin is one of the most crucial apoptosis inhibitory genes, playing a basic role in hepatocellular carcinoma (HCC) development and progression. The current study aims at investigating the relationship of survivin polymorphism with the risk of HCC in Hepatitis C virus-infected Egyptian population. Methods: the study was conducted on 120 Egyptian individuals divided into: healthy controls, fibrotic patients, cirrhotic patients and HCC patients (30 subjects/group). History and risk factors were collected and recorded for all cases. Polymorphism of the survivin gene, including one locus (rs9904341) was chosen for genotyping using (PCR-RFLP) technique. Results: No statistically significant difference was detected in the genotype or allele distribution of HCC subjects in respect to the controls (P>0.05). On the other hand, a significant difference could be detected in genotype or allele distribution in fibrosis and cirrhosis HCV patient groups compared to healthy controls (P<0.05). A significant difference in genotype or allele distribution was detected in HCC group compared to cirrhosis group (P<0.05). No statistically significant difference was found in genotype or allele distribution of fibrosis cases relative to the controls. Conclusion: No relationship between Survivin gene (-31G/C) polymorphism rs9904341 and the risk of HCC could be found in HCV-infected Egyptian population. However, a positive correlation could be detected between Survivin gene polymorphism and the risk of cirrhosis in the same population. The study also identified a relationship between survivin gene polymorphism in cirrhosis relative to fibrosis as well as between survivin gene (–31G/C) polymorphism rs9904341 in HCC relative to cirrhosis. | ||||
| Keywords | ||||
| survivin; -31G/C polymorphism; hepatocellular carcinoma; fibrosis | ||||
|
Statistics Article View: 290 PDF Download: 316 |
||||
